Research Site Index
250,000+ investigator records. 186 countries. 44,000+ distinct US institution labels. Monthly refresh with real-time updates on request. The intelligence layer behind AcceleTrial.
What the RSI Is
Most site lists in clinical research are static and unverified. RSI combines investigator search, list normalization, targeted output generation, feasibility packaging, and external market context in one sponsor-facing platform.
RSI Data Preview
Protocol-Aware Scoring Model
Every site in the RSI is scored across seven independent dimensions, recalculated for each protocol. The composite RSI score is what powers site ranking in AcceleTrial.
Therapeutic area depth, sub-specialty alignment, and prior protocol fit relative to the current study design.
Years on record, total trials conducted, phase distribution, and sponsor-relationship history for the named PI and sub-investigator team.
Demographic catchment data, local disease prevalence estimates, and historical enrollment conversion for the site's relevant indication.
On-time enrollment rate, screen failure rate, protocol deviation frequency, and FDA inspection outcomes across prior trials.
Depth of indication focus: sites with concentrated expertise in a single area score higher than broad general sites for protocol-specific studies.
Predictive enrollment velocity modeled from historical first-patient-in dates, contract-to-SIV timelines, and IRB turnaround benchmarks.
Staffing capacity, equipment on record, and prior experience with analogous study designs, structured and unstructured protocol match signals.
What Each Site Record Contains
Full PI and sub-investigator credentials, board certifications, publication history, active trial load, and years of experience by indication.
Historical enrollment rates against projected targets, broken down by phase, indication, and sponsor type across all prior trials.
FDA inspection records, audit outcomes, protocol deviation history, and Form 483 findings. Every compliance event on record.
Every prior engagement this site has had with sponsors and CROs: contracts executed, performance ratings, and communication history.
Demographic catchment analysis, disease prevalence in the site's geography, and patient pool estimates for specific indications.
IRB turnaround times, contract-to-SIV timelines, and first-patient-in dates from prior trials, giving a predictive view of activation speed.
Therapeutic Coverage
The current RSI runtime exposes 109 normalized specialty options covering virtually all therapeutic areas, with 44,000+ distinct US institution labels and global coverage across 186 countries.
How the RSI Stays Current
Site data decays fast. RSI data is refreshed monthly and can be updated in real-time when requested. Validation-backed source persistence and quality controls keep the intelligence layer current.
RSI data is refreshed on a monthly basis and can be updated in real time when requested by the sponsor or operations team.
Source persistence, shadow validation, and entity-quality workflows maintain trust in the data layer and make the intelligence asset harder to replicate.
Every new sponsor engagement is added to the site record as it concludes, building a longitudinal performance history over time.
Access the RSI
RSI access is available as a standalone product or as the data foundation behind an AcceleTrial engagement. Contact us to discuss what fits your program.